Valdes N, Alvarez V, Diaz-Cadorniga F, Aller J, Villazon F, Garcia I, Herrero A, Coto E
Servicio de Endocrinologia, Hospital, Central de Asturias, Oviedo, Spain.
Anticancer Res. 1998 Jul-Aug;18(4A):2685-9.
Multiple endocrine neoplasia (Menl) is an autosomai dominant hereditary trait characterized by tumors of endocrine tissues. The MEN1 gene maps to chromosome llql3, has been recently isolated, and encodes a protein termed menin that is ubiquitously expressed. This gene is likely to be a tumor suppressor gene, with tumors developing after the inactivation of both copies of the gene in a single cell. In agreement with this, 11q-deletions (loss of heterozygosity) are frequently found in neoplasms from MEN1 patients. In this study, DNA from family-members was extracted and analysed for 10 microsatellites flanking the MEN1-gene on chromosome 11q. SSCP was used to determine the presence of MEN1-mutations in several patients. DNA was extracted from paraffin blocks containing tissue from 10 parathyroid tumors (4 familial and 6 sporadic) and 2 gastrinomas (both from patients of the Men1-family). LOH was determined by comparing the autoradiographic patterns of several markers between the normal tissue and the malignant tissue counterpart. All the affected individuals in the MEN1-family shared one haplotype, not present in the healthy individuals. We searched for mutations at the MEN1 gene (SSCP-analysis) in several affected members. An SSCP-mobility shift was found at exon 9, and direct sequencing showed that this corresponded to a common polymorphism at codon 418 (GAC/GAT), LOH, a genetic alteration characteristic of genomic regions containing tumor suppressor genes, was found in all the parathyroid tumors, but not in two gastrinomas. SSCP-analysis of the MEN1-exon 9 polymorphism showed that LOH included the MEN1-gene in the informative parathyroid tumors. In conclusion, LOH at 11q is frequent in Menl-parathyroid tumors, either sporadic or familial, and the deletion involves the MEN1-gene. In contrast, the two gastrinomas did not show LOH, indicating the existence of a second mutation other than the MEN1-deletion in these tumors. Our data suggest that the mechanism that drives tumorigenesis in Menl either familial or sporadic, is influenced by the tissue context.
多发性内分泌腺瘤病(Menl)是一种常染色体显性遗传性状,其特征为内分泌组织肿瘤。MEN1基因定位于染色体11q13,最近已被分离出来,它编码一种名为menin的蛋白质,该蛋白质在全身广泛表达。该基因可能是一种肿瘤抑制基因,在单个细胞中该基因的两个拷贝均失活后才会发生肿瘤。与此相符的是,在MEN1患者的肿瘤中经常发现11q缺失(杂合性缺失)。在本研究中,提取了家庭成员的DNA,并对位于11号染色体q上MEN1基因两侧的10个微卫星进行了分析。采用单链构象多态性(SSCP)方法确定了部分患者中MEN1基因突变的存在情况。从含有10个甲状旁腺肿瘤(4个家族性和6个散发性)组织以及2个胃泌素瘤(均来自Men1家族的患者)组织石蜡块中提取DNA,并通过比较正常组织和恶性组织对应物中多个标记的放射自显影片段来确定杂合性缺失情况。MEN1家族中的所有患病个体都共享一种单倍型,而健康个体中不存在这种单倍型。我们对部分患病成员的MEN1基因进行了突变搜索(SSCP分析)。在第9外显子发现了SSCP迁移率改变现象,直接测序显示这对应于密码子418处的一个常见多态性(GAC/GAT)。杂合性缺失是含有肿瘤抑制基因的基因组区域的一种遗传改变特征,在所有甲状旁腺肿瘤中均有发现,但在两个胃泌素瘤中未发现这种情况。对MEN1第9外显子多态性进行SSCP分析表明,在有信息价值的甲状旁腺肿瘤中杂合性缺失包含MEN1基因。总之,11q杂合性缺失在Menl甲状旁腺肿瘤(无论是散发性还是家族性)中很常见,且缺失涉及MEN1基因。相比之下,两个胃泌素瘤未显示杂合性缺失,这表明在这些肿瘤中除了MEN1缺失外还存在第二种突变机制,我们的数据表明,无论是家族性还是散发性Menl中驱动肿瘤发生的机制都受组织环境影响,